Image Diagnostics has entered into a product development agreement with ECLS Inc. to design a new radiation shield expected to debut at the 2018 Radiological Society of North America (RSNA) 2018 annual meeting, Nov. 26-30 in Chicago. The radiation shield, conceptualized by ECLS founder James Goldstein, M.D., cardiologist at Royal Oak Michigan’s Beaumont Hospital, is expected to address the adverse health effects of radiation exposure and the strain of long-term wear of protective lead during interventional surgery.

The alliance of the IoT, machine learning and cloud technology is at the service of healthcare organizations, ready to assist them in optimizing the workflows.
Inga Shugalo

One by one, medical software systems become more interconnected, robust and helpful. In particular, many efforts are put into enhancing examination and diagnosis processes to enable precise and well-timed decisions, which are key to ensuring appropriate care delivery and predictable patient outcomes.

According to BreastCancer.org, an estimated 266,120 new cases of invasive breast cancer are expected to be diagnosed in the U.S. in 2018, along with 63,960 new cases of in situ breast cancer. About 1 in 8 U.S. women — around 12.4 percent — will develop invasive breast cancer over the course of her lifetime.

Enterprise imaging has been a hot topic in radiology and healthcare information technology (IT) circles for the last several years as medical image acquisition has moved beyond the exclusive purview of radiology.

Enterprise imaging has been a hot topic in radiology and healthcare information technology (IT) circles for the last several years as medical image acquisition has moved beyond the exclusive purview of radiology. 

Leica Biosystems announced the U.S. launch of MammoPort, the first integrated specimen containment and transport system for breast tissue biopsies.

A study of adherence to annual low-dose computed tomography (LDCT) screening within the Veteran Health Administration Lung Cancer Screening Demonstration Project (LCDSDP) revealed only 77.6 percent of those eligible for annual repeat scans returned. The study, from the Thoracic Oncology Research Group (TROG), Division of Pulmonary Critical Care, Medical University of South Carolina, will be presented at the CHEST Annual Meeting 2018, Oct. 6-10 in San Antonio.

Breast cancer recurrence rates for patients treated with the Xoft Axxent Electronic Brachytherapy (eBx) System that complied with adjuvant medical therapy were comparable to those seen in the TARGIT-A study that used different technology. Outcomes of the long-term study, with a mean follow-up of 55 months, were published in the The American Journal of Surgery.1 To date, this study presents the most long-term research of intraoperative radiation therapy (IORT) using the Xoft System published in a peer-reviewed journal.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now